Open AccessSusceptibility of Gram-Positive Cocci to Various Antibiotics, Including Cefotaxime, Moxalactam, and N -Formimidoyl Thienamycin
Author(s) -
Charles E. Cherubin,
Michael L. Corrado,
Marcelino F. Sierra,
Myles E. Gombert,
Michael A. Shulman
Publication year - 1981
Publication title -
antimicrobial agents and chemotherapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.07
H-Index - 259
eISSN - 1070-6283
pISSN - 0066-4804
DOI - 10.1128/aac.20.4.553
Subject(s) - moxalactam , thienamycin , cefotaxime , microbiology and biotechnology , penicillin , vancomycin , gram positive cocci , ampicillin , antibiotics , latamoxef , cephalosporin , medicine , staphylococcus aureus , biology , bacteria , genetics
The activities of cefotaxime, moxalactam, MK 0787 (N -formimidoyl thienamycin), ampicillin, oxacillin, vancomycin, and clindamycin were compared against gram-positive cocci. MK 0787 was the most active and moxalactam was the least active of these drugs, except against methicillin-resistantStaphylococcus aureus , where vancomycin was most active, and penicillin-resistant pneumococci, where cefotaxime was more active.